申请人:Schering Corporation
公开号:US05665735A1
公开(公告)日:1997-09-09
Disclosed is a compound of Formula 1.0: ##STR1## or a pharmaceutically acceptable salt or solvate thereof, wherein: AR.sup.1 represents ##STR2## AR.sup.2 represents ##STR3## or a five-membered heterocyclic aromatic group selected from the group consisting of Formulas I to XII, wherein the substitutable carbon atoms of the five-membered heterocyclic group can optionally be substituted with a group R.sup.1. Also disclosed are pharmaceutical compositions containing compounds of Formula 1.0. Further disclosed is a method for treating asthma, allergy and inflammation by administering an anti-asthmatic, anti-allergic or anti-inflammatory, respectively, effective amount of a compound of Formula 1.0.
揭示了一种Formula 1.0的化合物:##STR1##或其药学上可接受的盐或溶剂,其中:AR.sup.1代表##STR2## AR.sup.2代表##STR3##或从Formulas I到XII组成的选择的五元杂环芳基,其中五元杂环芳基的可替代碳原子可以选择性地被基团R.sup.1取代。还揭示了含有Formula 1.0化合物的药物组合物。进一步揭示了通过给予Formula 1.0化合物的有效量来治疗哮喘、过敏和炎症的方法,分别为抗哮喘、抗过敏或抗炎症。